Attached files
| file | filename |
|---|---|
| EX-10.28.2 - EX-10.28.2 - ALBIREO PHARMA, INC. | albo-ex10282_501.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20161231.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_562.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_530.htm |
| EX-23.2 - EX-23.2 - ALBIREO PHARMA, INC. | albo-ex232_542.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | albo-ex231_541.htm |
| EX-10.28.3 - EX-10.28.3 - ALBIREO PHARMA, INC. | albo-ex10283_502.htm |
| EX-10.28.1 - EX-10.28.1 - ALBIREO PHARMA, INC. | albo-ex10281_503.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2016 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 27, 2017 |
|
/s/ Ronald H.W. Cooper |
|
|
|
Ronald H.W. Cooper |
|
|
|
President and Chief Executive Officer (principal executive officer) |
|
Dated: March 27, 2017 |
|
/s/ Thomas A. Shea |
|
|
|
Thomas A. Shea |
|
|
|
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer) |